Platelet and INR Thresholds and Bleeding Risk in Ultrasound Guided Percutaneous Liver Biopsy: A Before-After Implementation of the 2019 Society of Interventional Radiology Guidelines Observational Quality Improvement Study
Open Access
- 16 May 2024
- journal article
- research article
- Published by SAGE Publications in Canadian Association of Radiologists Journal
- Vol. 75 (4) , 931-938
Abstract
Purpose: To evaluate if implementation of the 2019 Society of Interventional Radiology (SIR) guidelines for periprocedural management of bleeding risk in patients undergoing percutaneous ultrasound guided liver biopsy is associated with increased haemorrhagic adverse events, change in pre-procedural blood product utilization, and evaluation of guideline compliance rate at a single academic institution. Methods: Ultrasound guided percutaneous liver biopsies from (January 2019-January 2023) were retrospectively reviewed (n = 504), comparing biopsies performed using the 2012 SIR pre-procedural coagulation guidelines (n = 266) to those after implementation of the 2019 SIR pre-procedural guidelines (n = 238). Demographic, preprocedural transfusion, laboratory, and clinical data were reviewed. Chart review was conducted to evaluate the incidence of major bleeding adverse events defined as those resulting in transfusion, embolization, surgery, or death. Results: Implementation of the 2019 SIR periprocedural guidelines resulted in reduced guideline non-compliance related to the administration of blood products, from 5.3% to 1.7% ( P = .01). The rate of pre-procedural transfusion remained the same pre and post guidelines at 0.8%. There was no statistically significant change in the incidence of bleeding adverse events, 0.8% pre guidelines versus 0.4% post ( P = 1.0). Conclusion: Implementation of the 2019 SIR guidelines for periprocedural management of bleeding risk in patients undergoing percutaneous ultrasound guided liver biopsy did not result in an increase in bleeding adverse events or pre-procedural transfusion rates. The guidelines can be safely implemented in clinical practice with no increase in major adverse events.Keywords
Funding Information
- Queen's Department of Diagnostic Radiology
This publication has 13 references indexed in Scilit:
- Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: RecommendationsJournal of Vascular and Interventional Radiology, 2019
- Percutaneous liver biopsy and revised coagulation guidelines: a 9-year experienceAbdominal Radiology, 2017
- Platelet Transfusion Practices in the ICUChest, 2016
- Incidence and Risk Factors for Adverse Events Related to Image-Guided Liver BiopsyMayo Clinic Proceedings, 2016
- Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012Hepatology, 2013
- Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Image-guided InterventionsJournal of Vascular and Interventional Radiology, 2012
- Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C TrialClinical Gastroenterology and Hepatology, 2010
- Quality Improvement Guidelines for Percutaneous Needle BiopsyJournal of Vascular and Interventional Radiology, 2010
- Evidence-Based Incorporation of Serum Sodium Concentration Into MELDGastroenterology, 2006
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987